Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
31 May 2023
General Assembly, General meetings
Shares and voting rights statement – 2023 General Meeting
Open in new window
31 May 2023
General Assembly, General meetings
Proxy card – 2023 General Meeting
Open in new window
31 May 2023
General Assembly, General meetings
Preliminary notice of the 2022 General Meeting
Open in new window
10 May 2023
Financial statements and reports
2022 Universal Registration Document
Open in new window
25 April 2023
Corporate presentations
CORPORATE PRESENTATION-APRIL 2023
Open in new window
13 September 2022
Corporate presentations
CORPORATE PRESENTATION – SEPTEMBER 2022
Open in new window
02 September 2022
Regulated information
Statutes of the Company
Open in new window
28 July 2022
Financial statements and reports
2022 Half-Year Financial Report
Open in new window
25 May 2022
General meetings
2022 Remuneration policies
Open in new window
25 May 2022
General meetings
Results of the votes of the 2022 General Meeting
Open in new window
View previous 9 articles
1
…
3
4
5
6
7
8
9
10
11
12
13
…
21
View next 9 articles
Go back to the page of the page